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BACKGROUND 
• Whole genome sequencing 
• Human Genome Project completed in 2003 
 
• Personalized Medicine 
• Predictive Medicine (Risk) 
• Pharmacogenomics 
 
• Move from single gene to multiple gene  







• Direct to Consumer testing 
• https://www.23andme.com/health/all/   
 
 
Carrier Status (53) 
ARSACS * 
Agenesis of the Corpus Callosum with Peripheral Neuropathy (ACCPN) * 
Alpha-1 Antitrypsin Deficiency * 
Autosomal Recessive Polycystic Kidney Disease * 
BRCA Cancer Mutations (Selected) * 
Beta Thalassemia * 
Bloom's Syndrome * 
Canavan Disease * 
Congenital Disorder of Glycosylation Type 1a (PMM2-CDG) * 
Connexin 26-Related Sensorineural Hearing Loss * 
Cystic Fibrosis * 
D-Bifunctional Protein Deficiency * 
DPD Deficiency * 
Dihydrolipoamide Dehydrogenase Deficiency * 
Factor XI Deficiency * 
Familial Dysautonomia * 
Familial Hypercholesterolemia Type B * 
Familial Hyperinsulinism (ABCC8-related) * 
Familial Mediterranean Fever * 
Fanconi Anemia (FANCC-related) * 
G6PD Deficiency * 
GRACILE Syndrome * 
Gaucher Disease * 
Glycogen Storage Disease Type 1a * 
Glycogen Storage Disease Type 1b * 
Hemochromatosis (HFE-related) * 
Hereditary Fructose Intolerance * 
Hypertrophic Cardiomyopathy (MYBPC3 25bp-deletion) * 
LAMB3-related Junctional Epidermolysis Bullosa * 
Leigh Syndrome, French Canadian Type (LSFC) * 
Limb-girdle Muscular Dystrophy * 
Maple Syrup Urine Disease Type 1B * 
Medium-Chain Acyl-CoA Dehydrogenase (MCAD) Deficiency * 
Mucolipidosis IV * 
Neuronal Ceroid Lipofuscinosis (CLN5-related) * 
Neuronal Ceroid Lipofuscinosis (PPT1-related) * 
Niemann-Pick Disease Type A * 
Nijmegen Breakage Syndrome * 
Pendred Syndrome * 
Phenylketonuria * 
Primary Hyperoxaluria Type 2 (PH2) * 
Rhizomelic Chondrodysplasia Punctata Type 1 (RCDP1) * 
Salla Disease * 
Sickle Cell Anemia & Malaria Resistance * 
Drug Response (24) 
Abacavir Hypersensitivity * 




Clopidogrel (Plavix®) Efficacy * 
Floxacillin Toxicity 
Fluorouracil Toxicity * 
Hepatitis C Treatment Side Effects 
Heroin Addiction 
Lumiracoxib (Prexige®) Side Effects 
Metformin Response 
Naltrexone Treatment Response 
Oral Contraceptives, Hormone Replacement Therapy and Risk of Venous Thromboembolism * 
Phenytoin (Dilantin®) Sensitivity (Epilepsy Drug) * 
Postoperative Nausea and Vomiting (PONV) 
Pseudocholinesterase Deficiency * 
Response to Hepatitis C Treatment * 
Response to Interferon Beta Therapy 
Statin Response 
Sulfonylurea Drug Clearance (Type 2 Diabetes Treatment) * 
Thiopurine Methyltransferase Deficiency * 
Warfarin (Coumadin®) Sensitivity * 
Warfarin (Coumadin®) Sensitivity: Preliminary Research 
Traits (60) 
Adiponectin Levels 
Alcohol Flush Reaction * 
Asparagus Metabolite Detection 
Avoidance of Errors 
Biological Aging 
Birth Weight 
Bitter Taste Perception * 
Blood Glucose 
Breast Morphology 
Breastfeeding and IQ 
C-reactive Protein Level 
Caffeine Consumption 
Childhood and Adolescent Growth 
Chronic Hepatitis B 
Earwax Type * 
Eating Behavior 
Eye Color * 
Eye Color: Preliminary Research 
Finger Length Ratio 
Food Preference 
Freckling 
HDL ("Good") Cholesterol Levels 
HIV Progression 
Hair Color 
Hair Curl * 





LDL ("Bad") Cholesterol Levels 




Malaria Resistance (Duffy Antigen) * 
Male Pattern Baldness * 
Male Pattern Baldness: Preliminary Research 
Measures of Intelligence 




Muscle Performance * 
Disease Risk (122) 
Abdominal Aortic Aneurysm 
Age-related Macular Degeneration * 
Alcohol Dependence 
Alopecia Areata 
Alzheimer's Disease * 




Atrial Fibrillation * 
Atrial Fibrillation: Preliminary Research 
Attention-Deficit Hyperactivity Disorder 
Back Pain 
Basal Cell Carcinoma 
Behçet's Disease 
Bipolar Disorder * 
Bipolar Disorder: Preliminary Research 
Bladder Cancer 
Brain Aneurysm 
Breast Cancer * 
Breast Cancer Risk Modifiers 
Celiac Disease * 
Celiac Disease: Preliminary Research 
Chronic Kidney Disease * 
Chronic Lymphocytic Leukemia 
Chronic Obstructive Pulmonary Disease (COPD) 
Cleft Lip and Cleft Palate 
Cluster Headaches 
Colorectal Cancer * 
Coronary Heart Disease * 
Coronary Heart Disease: Preliminary Research 
Creutzfeldt-Jakob Disease 





Esophageal Cancer: Preliminary Research 
Esophageal Squamous Cell Carcinoma (ESCC) * 
Essential Tremor 





Glaucoma: Preliminary Research 
Gout * 
Gout: Preliminary Research 
Hashimoto's Thyroiditis 
Hay Fever (Allergic Rhinitis) 
Heart Rhythm Disorders (Arrhythmias) 










Lou Gehrig's Disease (ALS) 
Lung Cancer * 
Lupus (Systemic Lupus Erythematosus) * 
Male Breast Cancer 
Male Infertility 
Melanoma * 
Melanoma: Preliminary Research 
Meningioma 
Migraines 




Neural Tube Defects 
Neuroblastoma 
Nicotine Dependence 
Nonalcoholic Fatty Liver Disease 
Obesity * 
Obesity: Preliminary Research 
Obsessive-Compulsive Disorder 




Paget's Disease of Bone 
Pancreatic cancer 
Parkinson's Disease * 
Parkinson's Disease: Preliminary Research 
Peripheral Arterial Disease 
Placental Abruption 
Polycystic Ovary Syndrome 
Preeclampsia 
Primary Biliary Cirrhosis * 
Primary Biliary Cirrhosis: Preliminary Research 
Progressive Supranuclear Palsy 
Prostate Cancer * 
Psoriasis * 
Pulmonary Fibrosis 
Restless Legs Syndrome * 
Restless Legs Syndrome: Preliminary Research 




Scleroderma (Limited Cutaneous Type) * 
Scoliosis 
Selective IgA Deficiency 
Sjögren's Syndrome 
Squamous Cell Carcinoma 
Stomach Cancer (Gastric Cardia Adenocarcinoma) * 
Stomach Cancer: Preliminary Research 
Stroke 





Type 1 Diabetes * 
Type 2 Diabetes * 
Ulcerative Colitis * 
Uterine Fibroids 
Venous Thromboembolism * 
METHODS 
• Mailed paper survey to primary care physicians 
• 3 regional health systems 
•  Christiana Care Health System plus DAFP 
• Jefferson Health System 
• Lehigh Valley Health Network 
• Introductory letter with all 3 logos 
• $5 Wawa gift card 
• Supported by Dean’s office at TJU 
 
 
    




•n = 316 

















IN THE LAST 6 MONTHS HAVE YOU 







GENETIC TESTING ORDERED 
Testing (n) 










































































A 43 year-old woman comes to you concerned 
about her risk for cancer. You obtain a family history 
and discover that her father had colorectal cancer 
diagnosed at age 49 and a sister diagnosed with 
colorectal cancer at 45 years of age. 
HOW LIKELY WOULD YOU BE TO… 
CASE 2 
•  A 52 year old healthy man with an unremarkable 
family history tells you that he has had his blood 
drawn for a “full genetic analysis” (currently 
commercially available for less than $5000.) He 
wants to bring the results in to talk to you about your 
recommendations.  
HOW IMPORTANT ARE THE FOLLOWING 
BARRIERS TO DISCUSSING HIS RESULTS? 
CASE 3 
• You are seeing a 57-year old woman with a recent 
DVT for warfarin management. A lab report from 
her recent hospitalization includes information 
about genomic markers relevant to warfarin 
metabolism.  










Consult with a colleague or
anticoagulation specialist
Do independent reading to better
understand the implications of these
results





• Current state of Family History data in Electronic 
Medical Record 
 
• Availability and integration of resources at the point 
of care 
 
• Challenge of education initiatives in real world 
primary care 
USEFUL LINKS 
• GeneTests (select “GeneReviews”) : http://www.genetests.org 
• OMIM (Online Mendelian Inheritance in Man) : 
http://www.ncbi.nlm.nih.gov/sites/entrez?db=OMIM 
• Genes and Disease (NCBI) (organized by parts of the body affected): 
http://www.ncbi.nlm.nih.gov/books/bv.fcgi?rid=gnd 
• Chromosomal Variation in Man: 
http://www.wiley.com/legacy/products/subject/life/borgaonkar/ac
cess.html 
• National Coalition for Health Professional Education in Genetics: 
http//www.nchpeg.org 
• GeneTests (select “Educational Materials” and “Genetic Tools”): 
http//www.genetests.org 
• March of Dimes—Genetics and Your Practice: 
http//marchofdimes.com/gyponline/index.bm2 
 
 
 
THANK YOU 
